267 related articles for article (PubMed ID: 18022567)
1. Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth.
Lepesheva GI; Ott RD; Hargrove TY; Kleshchenko YY; Schuster I; Nes WD; Hill GC; Villalta F; Waterman MR
Chem Biol; 2007 Nov; 14(11):1283-93. PubMed ID: 18022567
[TBL] [Abstract][Full Text] [Related]
2. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis.
Lepesheva GI; Waterman MR
Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
4. Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.
Hargrove TY; Wawrzak Z; Alexander PW; Chaplin JH; Keenan M; Charman SA; Perez CJ; Waterman MR; Chatelain E; Lepesheva GI
J Biol Chem; 2013 Nov; 288(44):31602-15. PubMed ID: 24047900
[TBL] [Abstract][Full Text] [Related]
5. CYP51 from Trypanosoma cruzi: a phyla-specific residue in the B' helix defines substrate preferences of sterol 14alpha-demethylase.
Lepesheva GI; Zaitseva NG; Nes WD; Zhou W; Arase M; Liu J; Hill GC; Waterman MR
J Biol Chem; 2006 Feb; 281(6):3577-85. PubMed ID: 16321980
[TBL] [Abstract][Full Text] [Related]
6. Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum.
Hargrove TY; Wawrzak Z; Liu J; Nes WD; Waterman MR; Lepesheva GI
J Biol Chem; 2011 Jul; 286(30):26838-48. PubMed ID: 21632531
[TBL] [Abstract][Full Text] [Related]
7. Structural complex of sterol 14α-demethylase (CYP51) with 14α-methylenecyclopropyl-Delta7-24, 25-dihydrolanosterol.
Hargrove TY; Wawrzak Z; Liu J; Waterman MR; Nes WD; Lepesheva GI
J Lipid Res; 2012 Feb; 53(2):311-20. PubMed ID: 22135275
[TBL] [Abstract][Full Text] [Related]
8. CYP51 from Trypanosoma brucei is obtusifoliol-specific.
Lepesheva GI; Nes WD; Zhou W; Hill GC; Waterman MR
Biochemistry; 2004 Aug; 43(33):10789-99. PubMed ID: 15311940
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of Trypanosoma brucei sterol 14alpha-demethylase and implications for selective treatment of human infections.
Lepesheva GI; Park HW; Hargrove TY; Vanhollebeke B; Wawrzak Z; Harp JM; Sundaramoorthy M; Nes WD; Pays E; Chaudhuri M; Villalta F; Waterman MR
J Biol Chem; 2010 Jan; 285(3):1773-80. PubMed ID: 19923211
[TBL] [Abstract][Full Text] [Related]
10. CYP51 as drug targets for fungi and protozoan parasites: past, present and future.
Lepesheva GI; Friggeri L; Waterman MR
Parasitology; 2018 Dec; 145(14):1820-1836. PubMed ID: 29642960
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin amides as a novel molecular scaffold for targeting Trypanosoma cruzi sterol 14alpha-demethylase.
Konkle ME; Hargrove TY; Kleshchenko YY; von Kries JP; Ridenour W; Uddin MJ; Caprioli RM; Marnett LJ; Nes WD; Villalta F; Waterman MR; Lepesheva GI
J Med Chem; 2009 May; 52(9):2846-53. PubMed ID: 19354253
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit.
Chen CK; Doyle PS; Yermalitskaya LV; Mackey ZB; Ang KK; McKerrow JH; Podust LM
PLoS Negl Trop Dis; 2009; 3(2):e372. PubMed ID: 19190730
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of CYP51: implications for function and inhibitor design.
Yu X; Cojocaru V; Mustafa G; Salo-Ahen OM; Lepesheva GI; Wade RC
J Mol Recognit; 2015 Feb; 28(2):59-73. PubMed ID: 25601796
[TBL] [Abstract][Full Text] [Related]
14. Ligand tunnels in T. brucei and human CYP51: Insights for parasite-specific drug design.
Yu X; Nandekar P; Mustafa G; Cojocaru V; Lepesheva GI; Wade RC
Biochim Biophys Acta; 2016 Jan; 1860(1 Pt A):67-78. PubMed ID: 26493722
[TBL] [Abstract][Full Text] [Related]
15. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
[TBL] [Abstract][Full Text] [Related]
16. Biodiversity of CYP51 in trypanosomes.
Lepesheva GI; Hargrove TY; Ott RD; Nes WD; Waterman MR
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1161-4. PubMed ID: 17073776
[TBL] [Abstract][Full Text] [Related]
17. VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis.
Lepesheva GI; Hargrove TY; Rachakonda G; Wawrzak Z; Pomel S; Cojean S; Nde PN; Nes WD; Locuson CW; Calcutt MW; Waterman MR; Daniels JS; Loiseau PM; Villalta F
J Infect Dis; 2015 Nov; 212(9):1439-48. PubMed ID: 25883390
[TBL] [Abstract][Full Text] [Related]
18. Binding of a physiological substrate causes large-scale conformational reorganization in cytochrome P450 51.
Hargrove TY; Wawrzak Z; Fisher PM; Child SA; Nes WD; Guengerich FP; Waterman MR; Lepesheva GI
J Biol Chem; 2018 Dec; 293(50):19344-19353. PubMed ID: 30327430
[TBL] [Abstract][Full Text] [Related]
19. Sterol 14α-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae.
Friggeri L; Hargrove TY; Rachakonda G; Blobaum AL; Fisher P; de Oliveira GM; da Silva CF; Soeiro MNC; Nes WD; Lindsley CW; Villalta F; Guengerich FP; Lepesheva GI
J Med Chem; 2018 Dec; 61(23):10910-10921. PubMed ID: 30451500
[TBL] [Abstract][Full Text] [Related]
20. Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease.
Riley J; Brand S; Voice M; Caballero I; Calvo D; Read KD
PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004014. PubMed ID: 26394211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
